Psychopharmacology 1992: Vol 108 Index

3 Pages·1992·0.48 MB·English

Subject index of volume 108
Abstinence 495 Chick 235 Facilitation 443
Acetylcholine 417 Chlordiazepoxide 72, 263 Fear 352
Acetylcholinesterase-inhibitor 103 Chlorpromazine 289, 338, 345 FG 7142 185, 205
Acoustic startle response 40, 189 Cholinomimetics 11 Flumazenil 147
ACTH 27 Chronic cocaine treatment 263 Fluphenazine 338
Addiction 218, 397, 408 Chronic exposure 51 Food consumption 501
Adrenalectomy 27 Chronic treatment 33 FR 115
a-Adrenergic antagonists, atipamezole Cigarette 452
229 Cigarette smoking 1, 460, 495, 512 GABA 196
a-Adrenergic receptor 313 Clonazepam 131 Genetic 136
a,-Adrenergic antagonists, prazosin Clonidine 159, 283 Gepirone 289
229 Clovoxamine 327 Guanfacine 159
a&2-Adrenergic agonists, dexmedetomi- Cocaine 256, 295
dine 229 Cocaine abuse 289 Haloperidol 141, 338
Aerosol 519 Cocaine discontinuation 263 5-HT. receptor 387
Aggression 177, 196, 276 Cold pressor pain 60 5-HT3 333
Agonistic behavior 196 Conditioning 218 5-HT,, 123, 320
Alcohol 276 Conflict schedule 185 5-HT,, agonists 47
Alternative reinforcer 295 Consolidation 448 5-HT,, receptor 110
Alzheimer's disease 103, 480, 485 Continuous performance task reaction 5-HT,, receptors 85, 380
Ambulatory activity 271 time 437 5-HT,, 123
Amitriptyline 327 Controlled dosing 519 Human 103, 225, 345, 371
Amygdala 189 Corticosteroids 11 Human brain 16
Analgesia 60 Corticosterone 27, 33 Humans 51, 60
Animal behavior 196 Cortisol 153, 313
Animal model 352 Cortisol response 519 Idazoxan 313
Animal model of alcoholism 136 Cotinine 507 Imipramine 23
Animal models of anxiety 205 Cue learning 147 In vitro autoradiography 16
Antagonist 320 "C 16 Individuality 67
Anticholinergic 327 Infantile stimulation 170
Antidepressants 23, 93 Information processing 485
Defensive behavior 205
Antidepressants 327 Inhibitory avoidance learning 131
Demand 1
Antiepileptic drugs 131 Insomnia 67
Dementia 103
Antipredator defense 352 Inverse agonist 185
Dependence 218, 333, 408, 507
Antipsychotics 98
Depression 93
Anxiety 213, 313, 333, 352, 387 Kappa opioid receptor 235
Desipramine 363
Anxiogenic property 205 Ketanserin 27
Development 256
Anxiolysis 229 Ketanserine 210
Diazepam 131, 147, 301, 371
Apomorphine 47, 72, 367
Discrete-trials choice 295
Arginine-vasopressin 225 Late luteal phase dysphoric disorder
DO! 27
Arousal 456 153
Dopa decarboxylase 98
Attention 159, 485 Lateralisation 473
Dopamine 72, 177, 189, 256, 345, 367
Aversion 110 Learning 345, 480
Dopamine antagonists 289
Lithium 93
Dose-related 460
Locomotion 177, 196
Behavioral economics 1 Doxazosine 283
Locomotor activity 352, 367
Behaviour 283 DRL 115
Locus coeruleus 23
Benzodiazepine 72, 333 Drug abuse 60
Long-term memory 448
Benzodiazepine agonist, midazolam Drug discrimination 85
Lorazepam 345, 371
229 Drug interactions 115
Benzodiazepine antagonist, flumazenil Drug selfadministration 1
m-chlorophenylpiperazine 225
229 Drug stimulus exposure 495
MCPP 320
Benzodiazepine physical dependence Dynorphin 235
Mecamylamine 417, 480
301 D2 receptors 47
Memory 159, 235, 327, 345, 371, 417,
Benzodiazepine receptors 16
443, 452
Benzodiazepines 147, 196, 248, 371
EEG 473 Memory improvement 11
Beta-CCE 205
Electroconvulsive treatment 367 Mesolimbic dopamine system 141
Blood pressure 313
Elevated plus-maze 229 Methamphetamine sensitivity 271
Body weight 501
Emotional reactivity 170 MHPG 313
Brain levels 338
B-endorphin 153 Mice 131, 271, 276, 367
Bromperidol 338
Ethanol 301 Microeconomics 1
Bungarotoxin-receptors 33
Ethanol intake 136 MK-801 115, 271, 352, 367
Buspirone 289, 380
Etoperidone 320 Monkey brain 16
Euphoriant effects 460 Mood 60
Caffeine 51 Examination anxiety 456 Morphine 40, 60, 147, 283
Carbamazepine 131 Excitatory amino acid 110 Morphine-6-glucuronide 60
Carbon monoxide 466 Exploration 170 Morris water maze 147
Subject index of volume 108
Abstinence 495 Chick 235 Facilitation 443
Acetylcholine 417 Chlordiazepoxide 72, 263 Fear 352
Acetylcholinesterase-inhibitor 103 Chlorpromazine 289, 338, 345 FG 7142 185, 205
Acoustic startle response 40, 189 Cholinomimetics 11 Flumazenil 147
ACTH 27 Chronic cocaine treatment 263 Fluphenazine 338
Addiction 218, 397, 408 Chronic exposure 51 Food consumption 501
Adrenalectomy 27 Chronic treatment 33 FR 115
a-Adrenergic antagonists, atipamezole Cigarette 452
229 Cigarette smoking 1, 460, 495, 512 GABA 196
a-Adrenergic receptor 313 Clonazepam 131 Genetic 136
a,-Adrenergic antagonists, prazosin Clonidine 159, 283 Gepirone 289
229 Clovoxamine 327 Guanfacine 159
a&2-Adrenergic agonists, dexmedetomi- Cocaine 256, 295
dine 229 Cocaine abuse 289 Haloperidol 141, 338
Aerosol 519 Cocaine discontinuation 263 5-HT. receptor 387
Aggression 177, 196, 276 Cold pressor pain 60 5-HT3 333
Agonistic behavior 196 Conditioning 218 5-HT,, 123, 320
Alcohol 276 Conflict schedule 185 5-HT,, agonists 47
Alternative reinforcer 295 Consolidation 448 5-HT,, receptor 110
Alzheimer's disease 103, 480, 485 Continuous performance task reaction 5-HT,, receptors 85, 380
Ambulatory activity 271 time 437 5-HT,, 123
Amitriptyline 327 Controlled dosing 519 Human 103, 225, 345, 371
Amygdala 189 Corticosteroids 11 Human brain 16
Analgesia 60 Corticosterone 27, 33 Humans 51, 60
Animal behavior 196 Cortisol 153, 313
Animal model 352 Cortisol response 519 Idazoxan 313
Animal model of alcoholism 136 Cotinine 507 Imipramine 23
Animal models of anxiety 205 Cue learning 147 In vitro autoradiography 16
Antagonist 320 "C 16 Individuality 67
Anticholinergic 327 Infantile stimulation 170
Antidepressants 23, 93 Information processing 485
Defensive behavior 205
Antidepressants 327 Inhibitory avoidance learning 131
Demand 1
Antiepileptic drugs 131 Insomnia 67
Dementia 103
Antipredator defense 352 Inverse agonist 185
Dependence 218, 333, 408, 507
Antipsychotics 98
Depression 93
Anxiety 213, 313, 333, 352, 387 Kappa opioid receptor 235
Desipramine 363
Anxiogenic property 205 Ketanserin 27
Development 256
Anxiolysis 229 Ketanserine 210
Diazepam 131, 147, 301, 371
Apomorphine 47, 72, 367
Discrete-trials choice 295
Arginine-vasopressin 225 Late luteal phase dysphoric disorder
DO! 27
Arousal 456 153
Dopa decarboxylase 98
Attention 159, 485 Lateralisation 473
Dopamine 72, 177, 189, 256, 345, 367
Aversion 110 Learning 345, 480
Dopamine antagonists 289
Lithium 93
Dose-related 460
Locomotion 177, 196
Behavioral economics 1 Doxazosine 283
Locomotor activity 352, 367
Behaviour 283 DRL 115
Locus coeruleus 23
Benzodiazepine 72, 333 Drug abuse 60
Long-term memory 448
Benzodiazepine agonist, midazolam Drug discrimination 85
Lorazepam 345, 371
229 Drug interactions 115
Benzodiazepine antagonist, flumazenil Drug selfadministration 1
m-chlorophenylpiperazine 225
229 Drug stimulus exposure 495
MCPP 320
Benzodiazepine physical dependence Dynorphin 235
Mecamylamine 417, 480
301 D2 receptors 47
Memory 159, 235, 327, 345, 371, 417,
Benzodiazepine receptors 16
443, 452
Benzodiazepines 147, 196, 248, 371
EEG 473 Memory improvement 11
Beta-CCE 205
Electroconvulsive treatment 367 Mesolimbic dopamine system 141
Blood pressure 313
Elevated plus-maze 229 Methamphetamine sensitivity 271
Body weight 501
Emotional reactivity 170 MHPG 313
Brain levels 338
B-endorphin 153 Mice 131, 271, 276, 367
Bromperidol 338
Ethanol 301 Microeconomics 1
Bungarotoxin-receptors 33
Ethanol intake 136 MK-801 115, 271, 352, 367
Buspirone 289, 380
Etoperidone 320 Monkey brain 16
Euphoriant effects 460 Mood 60
Caffeine 51 Examination anxiety 456 Morphine 40, 60, 147, 283
Carbamazepine 131 Excitatory amino acid 110 Morphine-6-glucuronide 60
Carbon monoxide 466 Exploration 170 Morris water maze 147
Vil
Motor activity 177, 196 Place learning 147 Sleep 67, 213
mRNA levels 98 Platelet 210 Sleep-wakefulness 263
Positron emission tomography 16, 380 Slow wave sleep 387
N-allylnormetazocine 115 Prefrontal cortex 159 Smokers 519
Naloxone 40, 141, 147 Premenstrual symptoms 153 Smoking 408, 432, 437, 448, 456, 473
Naltrexon 79 Prenatal exposure 256 Snuff 507
Nasal nicotine spray 512 Prepulse inhibition 189 Social status 276
Nicotine 397, 408, 417, 443, 448, 452, Progressive-ratio 295 Spinal cord 123
456, 460, 466, 473, 480, 485, 501, Proponent process 79 Spinal reflexes 123
507, 519 Psychomotor performance 432 Statistical parametric mapping 380
Nicotine effects 512 Psychopharmacological effects 466 Stress 23, 276, 456
Nicotine gum 432 Punishment 185 Striatum 189
Nicotine pharmacokinetics 512 Subjective effects 51
Nicotine regulation 1 Quazepam 248 Subjective response 519
Nicotine replacement treatment 512 Quinpirole 72, 256 Substance withdrawal syndrome 67
Nicotine-tolerance 33 Sulpiride 72
Nicotinic 417 Radial arm maze 72 (+) S-20499 47
Nicotinic cholinergic-stress 33 Rat 40, 47, 147, 185, 229, 263, 283
NMDA antagonist 352 Rat brain 363 Tar 466
NMDA receptor 367 Rats 320 Tobacco use 397
Nociception 123 Rebound insomnia 67, 248 Tolerance 51, 218
Non-match-to-sample task 72 Reinforcement 51 Tomography, single photon emission
Nootropics 11 Reinstatement 79 computed 103
nor-binaltorphimine 235 Relapse 79, 218, 495 Trazodone 320
Norepinephrine 313 Repeated administration 271 Triazolam 67, 301
Nucleus accumbens 189 Repetition priming 371 Tricyclics 327
RFT (Reciprocal Forepaw Treading) Tryon rats 136
8-OH-DPAT 85 320 Tryptophan 60
Opiate 218 Rhesus monkey 289, 295 Tyrosine hydroxylase 23, 98
Opiates 177 Ritanserin 213, 263, 387 ['?5!] Tyr’ '-somatostatin binding sites
Opioid 218 Ro 15-4513 16 363
Opioid peptides 235 Roman high- and low-avoidance rats
Opioid receptor 141 170 UK-14.304 283
Opioids 79, 147 Unit price 1
Opponent process 79 Schedule-controlled behavior 115 U-50,488 235
Oral self-administration 301 Schizophrenia 98
Orbital cortex 189 SCH23390 72 Water consumption 501
Selective breeding 136 Wet-dog shakes 27
Peck-avoidance 235 Self-administration 79, 295 Withdrawal 40, 177, 218, 283
Penile erections 47 Self-administration of drugs 289 Withdrawal-deficit 437
Periaqueductal gray 110 Sensorimotor gating 189 Withdrawal effects 213
Perinatal flumazenil (Ro 15-1788) 170 Serotonin 60, 93, 110, 123, 153, 225, Working/episodic memory 72
FET 16 320
Pharmacological challenge 380 Serotonin receptors 210 Yawning 47
Phencyclidine 115 Serotonin-2 (5-HT2 ) binding site 27 Yohimbine 313
Phenylpropanolamine 501 Sex differences 352
Phenytoin 131 Short-term memory 485 Zacopride 333
Physical dependence 40, 51 SKF38393 72 Zolpidem 248
Physiological response 519 SKF104078 159 Zopiclone 248